Views & Analysis Pharma improves HCP engagement during COVID-19 – report Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs.
Views & Analysis What HCPs think about pharma For a long time, I have been observing how healthcare professionals (HCPs) are talking about the pharmaceutical industry – including their conversations about how the pharmaceutical industr
News Just how radical is the FDA's complete response letter move? The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face